Leave Your Message
ADT1663-Toripalimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade
Hot

ADT1663-Toripalimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade

  • Catalog Number ADT1663
  • Host CHO Cells
  • Species Human
  • Target PDCD1/PD-1/CD279
  • Application Elisa, WB

PDCD1 transmits inhibitory signals when binding to ligands CD274/PCDD1L1 and CD273/PCDD1LG2. After the involvement of T cell receptors (TCR), PDCD1 binds to CD3-TCR in the immune synapse, directly inhibiting T cell activation (through similarity). Inhibition of T cell activation through recruitment of PTPN11/SHP-2: After ligand binding, PDCD1 is phosphorylated within the ITSM motif, leading to recruitment of tyrosine phosphatase PTPN11/SHP-2, which mediates the dephosphorylation of key TCR proximal signaling molecules such as ZAP70, PRKCQ/PKCtheta, and CD247/CD3zeta.

Our biosimilar antibodies are carefully designed for research, ensuring reliability and effectiveness. Available in small or large quantities, they are ideal for both research and commercial applications.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

PD1, Programmed cell death 1, PDCD1 (CD279, hSLE 1, PD-1, SLEB 2), a member of the CD28 superfamily, is a type I transmembrane protein composed of 268 amino acids. It was discovered by a Japanese professor in 1992 and is expressed on the surface of immune cells such as T cells and B cells. However, T cells hardly expressed PD-1 when not activated, and only after T-cell activation was the PD-1 expressed on the T-cell surface.

Product Specification

Catalog Number

ADT1663

Product Name

ADT1663-Toripalimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade

Isotype

IgG4 Kappa

Clonity

Monoclonal

Alternate Names

anti-mouse pd-1 antibody, anti-pd-1 antibody, anti pd-1 therapy, anti pd-1 antibody, recombinant pd-1, pd-1 antibody, anti-pd-1 monoclonal antibody, CD279 antibody, anti CD279, anti-CD279 antibody, human CD279 antibody, recombinant CD279, CD279 recombinant antibody, CD279 blocking antibody

Official Symbol

PDCD1/PD-1/CD279

Species

Human

Expression Host

CHO Cells

Reactivity

Human

CAS Number

1924598-82-2

Product Description

Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1.  Toripalimab is able to bind to PD-1 and block the interaction with its ligands.

Mechanism of Action

Toripalimab is a monoclonal antibody targeting PD-1.

Metabolism

Toripalimab has a long half-life and is distributed throughout the bloodstream and tissues.

Gene ID

5133

Size

100ug,1mg,5mg

Research Area

Cancer

Application

Elisa, WB

Purity

>95% as determined by SDS-PAGE

Concentration

Batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only. 

Reference

1. Ma Y, et al. Zhonghua Yu Fang Yi Xue Za Zhi, 2023 Jun 6. PMID 37357205
2. Mirsharif ES, et al. Int Immunopharmacol, 2023 Jun. PMID 37172423
3. Tarique M, et al. Front Immunol, 2023. PMID 37153623

 

FAQ

Leave Your Message